Genetic Signatures Wins Contract From Public Health Wales for Enteric Pathogen Testing
Under the three-year contract, worth up to A$1.8 million (US$1.4 million) per year, the Australian firm will provide testing to seven sites within Wales.
Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.
Mobidiag Secures €25M Loan to Build Test Menu
The four-year loan will be used to develop molecular diagnostic assays for the firm's two test systems, Amplidiag and Novodiag.
Cincinnati, Ohio-based Meridian will acquire Quebec City-based GenePOC for $120 million, and hopes to quickly convert customers to a PCR-based instrument.
Luminex has since fixed the problem with a software update but a similar issue with non-specific amplification has also affected two targets on BioFire's GI panel.